INS and Hyperglycemia: The ability to use a point-of-care sensor to measure insulin concurrently with glucose would allow for a much better assessment of endogenous insulin activity, enabling real-time adjustments in insulin dosing to be made while minimising the likelihood of occurrence of extremes of hypoglycaemia or hyperglycaemia.